Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.

NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators

TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.

METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help

NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product

COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors

INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
AMTD Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: March 30, 2026
Report Source: 2025 2nd Quarter Report
AMTD IDEA Group. Stock Analysis AMTD
AMTD IDEA Group is a FR-based company operating in Capital Markets industry. The company is headquartered in Paris, Ile-De-France and currently employs 214 full-time employees. The company went IPO on 2019-08-05. AMTD IDEA Group, formerly AMTD International Inc, is an investment holding company principally engaged in the strategic investments. The firm operates its business through three segments. The Strategic Investment segment engages in proprietary investments and the management of investment portfolios mainly focusing on financial services and asset classes. The Investment Banking segment is involved in raising funds through equity and debt financing, providing underwriting for initial public offerings (IPOs), private placements and debt issuances and providing financial advisory services. The Asset Management segment provides asset management products and services, including in relation to listed equities, fixed income securities, hedge funds, structured products, foreign exchange, private equities, alternative investments, discretionary account services, investment advisory services and external asset management services.
Read More AMTD IDEA Group (AMTD) Chart
Key Statistics of AMTD IDEA Group (AMTD)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$1.01Volume
13.12KP/E Ratio (TTM)
29.1952 Week Range
Market Cap
1.51BAvg. Volume
31.37KDividend Yield
-Financial Metrics & Statements of AMTD IDEA Group (AMTD)
FAQ's for AMTD IDEA Group (AMTD)
- According to Musaffa’s Shariah screening methodology, AMTD IDEA Group (AMTD) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes AMTD IDEA Group using these criteria to determine its compliance status.
- Muslim investors may consider investing in AMTD IDEA Group if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of AMTD IDEA Group by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of AMTD IDEA Group may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of AMTD IDEA Group on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.